SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVX
July 26, 2024 10:25 ET
|
Pomerantz LLP
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HilleVax, Inc. (“HilleVax” or the “Company”) (NASDAQ: HLVX). Such investors are advised...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ServiceNow, Inc. - NOW
July 26, 2024 10:20 ET
|
Pomerantz LLP
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ServiceNow, Inc. (“ServiceNow” or the “Company”) (NYSE: NOW). Such investors are advised...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CenterPoint Energy, Inc. - CNP
July 26, 2024 10:17 ET
|
Pomerantz LLP
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CenterPoint Energy, Inc. (“CenterPoint” or the “Company”) (NYSE: CNP). Such investors...
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Stock of Y-mAbs Therapeutics, Inc. - YMAB
July 22, 2024 08:00 ET
|
Pomerantz LLP
NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the Southern District of New York has approved the following announcement of a proposed...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ODDITY Tech Ltd. of Class Action Lawsuit and Upcoming Deadlines – ODD
July 20, 2024 19:35 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ODDITY Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD) and certain officers...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE
July 20, 2024 16:50 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. (“Skye” or the “Company”) (NASDAQ: SKYE). Such investors are advised...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Target Hospitality Corp. - TH
July 20, 2024 16:47 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Target Hospitality Corp. (“Target Hospitality” or the “Company”) (NASDAQ: TH). Such...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against CAE Inc. – CAE
July 20, 2024 16:45 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CAE Inc. (“CAE” or the “Company”) (NYSE: CAE). Such investors are advised to...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
July 20, 2024 16:43 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ovid Therapeutics Inc. (“Ovid” or the “Company”) (NASDAQ: OVID). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Salesforce, Inc. - CRM
July 20, 2024 16:42 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Salesforce, Inc. (“Salesforce” or the “Company”) (NYSE: CRM). Such investors are advised...